Risk of coronary artery disease after adjuvant radiotherapy in 29,662 early breast cancer patients: A population-based Danish Breast Cancer Group study

被引:45
作者
Milo, Marie Louise Holm [1 ]
Thorsen, Lise Bech Jellesmark [1 ,2 ]
Johnsen, Soren Paaske [3 ]
Nielsen, Kirsten Melgaard [4 ]
Valentin, Jan Brink [3 ]
Alsner, Jan [1 ]
Offersen, Birgitte Vrou [1 ,2 ,5 ]
机构
[1] Aarhus Univ Hosp, Dept Expt Clin Oncol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark
[2] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark
[3] Aalborg Univ Hosp, Danish Ctr Clin Hlth Serv Res, Dept Clin Med, Aarhus, Denmark
[4] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark
[5] Danish Ctr Particle Therapy, Aarhus, Denmark
关键词
Breast cancer; Radiotherapy; Coronary artery disease; Valvular heart disease; Long-term side effects; COOPERATIVE GROUP; POSTOPERATIVE RADIOTHERAPY; HEART-DISEASE; NODE IRRADIATION; DBCG-IMN; WOMEN; DENMARK;
D O I
10.1016/j.radonc.2021.01.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Radiotherapy (RT) for early breast cancer (BC) reduces the risk of recurrence and improves over-all survival. However, thoracic RT may cause some incidental RT dose to the heart with subsequent risk of heart disease. During 2000-2010, CT-based RT planning was gradually introduced. The aim of this study was to investigate the risk of cardiac events in left-sided compared with right-sided BC patients treated during a non-CT-based (1999-2007) vs a CT-based period (2008-2016). Material and methods: Information on BC and cardiac events among Danish women was obtained from population-based medical registers. Patients diagnosed with BC during 1999-2016, were included. A car-diac event was defined as coronary artery disease or severe valvular heart disease. Results: Among 29,662 patients, 22,056 received RT. For those irradiated during the non-CT-based period, the 10-year cumulative risk of cardiac event was 1.7% (95% CI 1.4-2.0) at median follow-up of 11.1 years. The incidence rate ratio (IRR) for cardiac event in left-sided vs right-sided patients was 1.44 (1.07-1.94) anda trend towards worse outcome was seen within the first 10 years after RT and approached statistical significance with longer follow-up. Among patients irradiated during the CT-based period, the 10-year cumulative risk of cardiac event was 2.1% (1.8-2.4) at median 6.8 years follow-up. The IRR for cardiac event in left-sided vs right-sided patients was 0.90 (0.69-1.16) and no trend towards worse outcome within the first 10 years was observed. Conclusion: This study confirmed a higher risk of cardiac events in left-sided vs right-sided BC patients irradiated during a non-CT-based period. For patients irradiated during a CT-based period, no increased risk of cardiac events in left-sided vs right-sided patients was observed within the first 10 years after RT, whilst information on cardiac events beyond 10 years after RT was limited. (C) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页码:106 / 113
页数:8
相关论文
共 35 条
[1]  
[Anonymous], HJERTEKATETERISATION
[2]   The potential benefits from respiratory gating for breast cancer patients regarding target coverage and dose to organs at risk when applying strict dose limits to the heart: results from the DBCG HYPO trial [J].
Berg, Martin ;
Lorenzen, Ebbe L. ;
Jensen, Ingelise ;
Thomsen, Mette S. ;
Lutz, Christina Maria ;
Refsgaard, Lasse ;
Nissen, Henrik D. ;
Offersen, Birgitte V. .
ACTA ONCOLOGICA, 2018, 57 (01) :113-119
[3]   Danish Breast Cancer Cooperative Group - DBCG: History, organization, and status of scientific achievements at 30-year anniversary [J].
Blichert-Toft, Mogens ;
Christiansen, Peer ;
Mouridsen, Henning T. .
ACTA ONCOLOGICA, 2008, 47 (04) :497-505
[4]   Prognosis of acute coronary syndromes after radiotherapy for breast cancer [J].
Boekel, Naomi B. ;
Boekel, Lynnly Y. ;
Buddeke, Josefien ;
Jacobse, Judy N. ;
Schaapveld, Michael ;
Hooning, Maartje J. ;
Seynaeve, Caroline M. ;
Baaijens, Margreet H. A. ;
Sonke, Gabe S. ;
Rutgers, Emiel J. T. ;
Russell, Nicola S. ;
Maas, Angela H. E. M. ;
Vaartjes, Ilonca ;
Aleman, Berthe M. P. ;
van Leeuwen, Flora E. .
RADIOTHERAPY AND ONCOLOGY, 2020, 146 :110-117
[5]   Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer [J].
Boekel, Naomi B. ;
Jacobse, Judy N. ;
Schaapveld, Michael ;
Hooning, Maartje J. ;
Gietema, Jourik A. ;
Duane, Frances K. ;
Taylor, Carolyn W. ;
Darby, Sarah C. ;
Hauptmann, Michael ;
Seynaeve, Caroline M. ;
Baaijens, Margreet H. A. ;
Sonke, Gabe S. ;
Rutgers, Emiel J. T. ;
Russell, Nicola S. ;
Aleman, Berthe M. P. ;
van Leeuwen, Flora E. .
BRITISH JOURNAL OF CANCER, 2018, 119 (04) :408-418
[6]   Danish Breast Cancer Cooperative Group [J].
Christiansen, Peer ;
Ejlertsen, Bent ;
Jensen, Maj-Britt ;
Mouridsen, Henning .
CLINICAL EPIDEMIOLOGY, 2016, 8 :445-449
[7]   Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer [J].
Darby, Sarah C. ;
Ewertz, Marianne ;
McGale, Paul ;
Bennet, Anna M. ;
Blom-Goldman, Ulla ;
Bronnum, Dorthe ;
Correa, Candace ;
Cutter, David ;
Gagliardi, Giovanna ;
Gigante, Bruna ;
Jensen, Maj-Britt ;
Nisbet, Andrew ;
Peto, Richard ;
Rahimi, Kazem ;
Taylor, Carolyn ;
Hall, Per .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (11) :987-998
[8]   Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials [J].
Darby S. ;
McGale P. ;
Correa C. ;
Taylor C. ;
Arriagada R. ;
Clarke M. ;
Cutter D. ;
Davies C. ;
Ewertz M. ;
Godwin J. ;
Gray R. ;
Pierce L. ;
Whelan T. ;
Wang Y. ;
Peto R. ;
Albain K. ;
Anderson S. ;
Barlow W. ;
Bergh J. ;
Bliss J. ;
Buyse M. ;
Cameron D. ;
Carrasco E. ;
Coates A. ;
Collins R. ;
Costantino J. ;
Cuzick J. ;
Davidson N. ;
Davies K. ;
Delmestri A. ;
Di Leo A. ;
Dowsett M. ;
Elphinstone P. ;
Evans V. ;
Gelber R. ;
Gettins L. ;
Geyer C. ;
Goldhirsch A. ;
Gregory C. ;
Hayes D. ;
Hill C. ;
Ingle J. ;
Jakesz R. ;
James S. ;
Kaufmann M. ;
Kerr A. ;
MacKinnon E. ;
McHugh T. ;
Norton L. ;
Ohashi Y. .
LANCET, 2011, 378 (9804) :1707-1716
[9]   Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration [J].
Ejlertsen, Bent ;
Offersen, Birgitte Vrou ;
Overgaard, Jens ;
Christiansen, Peer ;
Jensen, Maj-Britt ;
Kroman, Niels ;
Knoop, Ann Sogaard ;
Mouridsen, Henning .
ACTA ONCOLOGICA, 2018, 57 (01) :3-12
[10]  
Erichsen Rune, 2010, Clin Epidemiol, V2, P51